Potomac Analytics' Logo

Broker-Dealers on SEC Form D for AEGIS CAPITAL CORP.

Form Ds provide information on individual, unregistered securities offerings.

Search by Recipient Name or Primary Issuer:

Filter by:

Sort by:

Displaying 10 out of 74 results
Recipient CRD Primary Issuer CIK Filing Date Form Type Total Offering Amount Total Amount Sold
AEGIS CAPITAL CORP.15007Aquyre Biosciences Inc188737705/13/2022D/A$5,000,000$4,999,995
AEGIS CAPITAL CORP.15007Sunshine Biopharma, Inc140232805/17/2023D$4,996,497$4,996,497
AEGIS CAPITAL CORP.15007BIO BLAST PHARMA LTD.159681202/13/2014D$4,750,000$4,750,000
AEGIS CAPITAL CORP.15007Aerami Therapeutics Holdings, Inc.165084006/17/2020D$15,000,000$4,608,000
AEGIS CAPITAL CORP.15007Nxt-ID, Inc.156682607/28/2016D$4,500,000$4,500,000
AEGIS CAPITAL CORP.15007Aegis Special Situations Fund LLC - Series Aerospace II187703208/05/2021D$5,000,000$4,465,000
AEGIS CAPITAL CORP.15007Shopoff Opportunity Fund VI, L.P.174503702/01/2019D/A$100,000,000$4,409,737
AEGIS CAPITAL CORP.15007Shopoff Opportunity Fund VI, L.P.174503703/13/2019D/A$100,000,000$4,409,737
AEGIS CAPITAL CORP.15007Shopoff Opportunity Fund VI, L.P.174503703/15/2019D/A$100,000,000$4,409,737
AEGIS CAPITAL CORP.15007Shopoff Opportunity Fund VI, L.P.174503704/04/2019D/A$100,000,000$4,409,737

74 Results

Display: